NCT07802301

Brief Summary

This study evaluates the safety, feasibility, and preliminary effects of transcutaneous auricular vagus nerve stimulation (taVNS) paired with an oral sensorimotor training protocol in infants with severe dysphagia. Infants with significant sucking and swallowing impairment will receive twice-daily taVNS paired with oromotor training over a three-week period. Outcomes include swallowing mechanics, sucking proficiency, and functional feeding performance assessed before and after the intervention.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
6mo left

Started Aug 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress16%
Aug 2026Mar 2027

Study Start

First participant enrolled

August 30, 2026

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

August 31, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 3, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2027

Last Updated

September 3, 2026

Status Verified

August 1, 2026

Enrollment Period

7 months

First QC Date

August 31, 2026

Last Update Submit

August 31, 2026

Conditions

Keywords

Transcutaneous Auricular Vagus Nerve StimulationOromotor TrainingDysphagiaFeeding Disorders

Outcome Measures

Primary Outcomes (5)

  • Change in swallowing impairment as measured by the BaByVFSImP

    Swallowing mechanics will be assessed using the Baby Videofluoroscopic Swallow Study Impairment Profile, a standardized scoring tool used to evaluate physiologic components of infant swallowing during videofluoroscopic swallow study. Scores will be compared from pre-treatment to post-treatment to determine change in swallowing impairment. Lower scores indicate less impairment.

    Pre-treatment baseline and post-treatment, following completion of the 3-week intervention period

  • Change in airway protection as measured by the Penetration-Aspiration Scale

    Airway protection during swallowing will be assessed using the Penetration-Aspiration Scale from videofluoroscopic swallow study recordings. Scores describe the depth of airway invasion and the infant's response to material entering the airway. Scores will be compared from pre-treatment to post-treatment. Lower scores indicate better airway protection.

    Pre-treatment baseline and post-treatment, following completion of the 3-week intervention period

  • Change in early feeding skills as measured by the Early Feeding Skills Assessment

    Feeding skills will be assessed using the Early Feeding Skills Assessment, a standardized clinical assessment used to evaluate infant feeding readiness, oral feeding skills, physiologic stability, and feeding tolerance. Scores will be compared from pre-treatment to post-treatment to evaluate change in functional feeding performance. Higher scores indicate more mature or more effective feeding skills.

    Pre-treatment baseline and post-treatment, following completion of the 3-week intervention period

  • Change in sucking pressures

    Sucking pressures will be measured. Values will be compared from pre-treatment to post-treatment to evaluate change in sucking mechanics.

    Pre-treatment baseline and post-treatment, following completion of the 3-week intervention period

  • Change in oral feeding volume

    Oral feeding volume will be measured as the amount of prescribed feeding volume taken orally. Oral intake volume will be compared from pre-treatment to post-treatment to determine change in functional oral feeding ability. Greater oral intake volume indicates improved feeding performance.

    Pre-treatment baseline and post-treatment, following completion of the 3-week intervention period

Secondary Outcomes (6)

  • Number of bradycardia events during intervention

    During each intervention session throughout the 3-week intervention period

  • Number of oxygen desaturation events during intervention

    During each intervention session throughout the 3-week intervention period

  • Number of coughing or choking episodes during intervention

    During each intervention session throughout the 3-week intervention period

  • Intervention completion rate

    End of the 3-week intervention period

  • Protocol adherence rate

    Throughout the 3-week intervention period

  • +1 more secondary outcomes

Study Arms (1)

taVNS Paired Oromotor Training

EXPERIMENTAL

Infants will receive transcutaneous auricular vagus nerve stimulation (taVNS) paired with an oral sensorimotor training protocol twice daily for 15 days over three weeks.

Device: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)Behavioral: Oral Sensorimotor Training Protocol

Interventions

A structured oromotor stimulation protocol including stimulation of lips, tongue, cheeks, and palate, along with non-nutritive sucking and feeding practice as appropriate.

taVNS Paired Oromotor Training

A non-invasive neuromodulation intervention delivered via electrodes placed on the ear tragus. Electrical stimulation is delivered at low intensity during feeding-related oromotor training sessions.

taVNS Paired Oromotor Training

Eligibility Criteria

AgeUp to 6 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infants ≥37 weeks post-menstrual age
  • Diagnosed with dysphagia and significant sucking/swallowing impairment
  • Limited oral feeding ability
  • Admitted to NICU

You may not qualify if:

  • Cardiomyopathy
  • Unstable bradycardia
  • Significant respiratory support requirement
  • Absence of gag reflex
  • Inability to manage secretions
  • Infants of poorly controlled diabetic mothers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Deglutition DisordersFeeding and Eating Disorders

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic DiseasesSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Central Study Contacts

Heather C McGhee, PhD

CONTACT

Doe Jenkins, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 31, 2026

First Posted

September 3, 2026

Study Start

August 30, 2026

Primary Completion (Estimated)

March 31, 2027

Study Completion (Estimated)

March 31, 2027

Last Updated

September 3, 2026

Record last verified: 2026-08